Poly(sodium 4-styrene sulfonate): Evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice

Clinical Microbiology and Infection

Volumn 9, Issue 8, 2003, Pages 816-822

  Bourne, N ^a   Zaneveld, L J D ^b   Ward, J A ^a   Ireland, J P ^a   Stanberry, L R ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chlamydia; HSV 2; Mice; Topical microbicide

Indexed keywords

POLYSTYRENESULFONATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GEL; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IN VIVO STUDY; INCIDENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM; STATISTICAL SIGNIFICANCE; VAGINITIS;

ANIMALIA; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 0141516252     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00659.x     Document Type: Article

References (31)

1. Rosenberg MJ, Gollub EL. Methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992; 82: 1473-8.
2. Zaneveld LJD, Anderson DJ, Whaley KJ. Barrier methods. In: Harrison PF, Rosenfeld A, eds. Contraceptive research and development, looking into the future. Washington, DC: National Academic Press, 1996: 430-73.
3. Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Antiviral Res 1999; 43: 157-73.
4. Jennings R, Clegg A. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro. J Antimicrob Chemother 1993; 32: 71-82.
5. Asculai SS, Weis MT, Rancourt MW, Kupferberg AB. Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother 1978; 13: 686-90.
6. Benes S, McCormack WM. Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agents Chemother 1985; 27: 724-6.
7. Patton DL, Wang S-K, Kuo C-C. In vitro activity of nonoxynol-9 on HeLa 229 cells and primary monkey cervical cells infected with Chlamydia trachomatis. Antimicrob Agents Chemother 1992; 36: 1478-82.
8. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991; 18: 176-9.
9. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4: 165-70.
10. Stafford MK, Ward H, Flanagan A et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J AIDS Hum Retrovirol 1997; 17: 327-31.
11. Rosenstein IJ, Stafford MK, Kitchen VS, Ward H, Weber JN, Taylor-Robinson D. Effect on normal vaginal flora of three intravaginal microbial agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998; 177: 1386-90.
12. Richardson BA, Martin HL, Stevens CE et al. Use of nonoxynol-9 and changes in vaginal lactobacilli. J Infect Dis 1998; 178: 441-5.
13. Stephenson J. Widely used spermicide may increase, not decrease, risk of HIV transmission. JAMA 2000; 284: 949.
14. Bourne N, Bernstein DI, Ireland J, Sonderfan AJ, Profy AT, Stanberry LR. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis 1999; 180: 203-5.
15. Van Damme L, Wright A, Depraetere K et al. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect 2000; 76: 126-30.
16. Zacharopoulos VR, Phillips DM. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin Diagn Lab Immunol 1997; 4: 465-8.
17. Gyotoku T, Aurelian L, Neurath AR. Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection. Antiviral Chem Chemother 1999; 10: 327-32.
18. Zeitlin L, Whaley KJ, Hegarty TA, Moench TR, Cone RA. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 1997; 56: 329-35.
19. Bourne N, Stanberry LR, Kern ER, Holan G, Matthews B, Bernstein DI. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother 2000; 44: 2471-4.
20. Zaneveld LJD, Waller DP, Anderson RA et al. Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly (sodium 4-styrenesulfonate). Biol Reproduct 2002; 66: 886-94.
21. Herold BC, Bourne N, Marcellino D et al. Poly (sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. J Infect Dis 2000; 181: 770-3.
22. Stanberry LR, Bernstein DI, Burke RL, Pachl C, Myers MG. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis 1987; 155: 914-20.
23. Cooper MD, Rapp J, Jeffery-Wiseman C, Barnes RC, Stephens DS. Chlamydia trachomatis infection of human fallopian tube organ cultures. Gen Microbiol 1990; 136: 1109-15.
24. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human Reprod Update 1999; 5: 433-47.
25. Burillo CA, Fontenot JD, Phillips DM. Sulfated polysaccharides block chlamydia infection in vitro, but do not protect mice from vaginal inoculation. Microb Pathogen 1998; 24: 253-6.
26. Su H, Caldwell HD. Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydia genital tract infection. Infect Immun 1998; 66: 1258-60.
27. Erickson PI, Bastani R, Maxwell AE, Marcus AC, Capell FJ, Yan KX. Prevalence of anal sex among heterosexuals in California and its relationship to other AIDS risk behaviours. AIDS Educ Prev 1995; 7: 477-93.
28. Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDS 1999; 13: 717-30.
29. Baldwin JI, Baldwin JD. Heterosexual anal intercourse: an understudied, high-risk sexual behaviour. Arch Sex Behav 2000; 29: 357-73.
30. Phillips DM, Taylor CL, Zacharopoulos VR, Maguire RA. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception 2000; 62: 149-54.
31. Phillips DM, Zacharopoulos VR. Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. Contraception 1998; 57: 341-8.